Gamco Investors INC. ET AL Boosts Position in Patterson Companies, Inc. (NASDAQ:PDCO)

Gamco Investors INC. ET AL increased its holdings in Patterson Companies, Inc. (NASDAQ:PDCOFree Report) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 723,257 shares of the company’s stock after acquiring an additional 55,125 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Patterson Companies were worth $22,320,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PDCO. Gabelli Funds LLC increased its position in shares of Patterson Companies by 82.5% during the fourth quarter. Gabelli Funds LLC now owns 217,150 shares of the company’s stock valued at $6,701,000 after buying an additional 98,150 shares during the period. Guggenheim Capital LLC boosted its position in shares of Patterson Companies by 137.3% during the fourth quarter. Guggenheim Capital LLC now owns 42,989 shares of the company’s stock valued at $1,327,000 after purchasing an additional 24,872 shares in the last quarter. Mariner LLC purchased a new stake in Patterson Companies in the fourth quarter worth $520,000. Barclays PLC raised its holdings in Patterson Companies by 6.7% in the fourth quarter. Barclays PLC now owns 176,752 shares of the company’s stock worth $5,455,000 after purchasing an additional 11,037 shares in the last quarter. Finally, SageView Advisory Group LLC purchased a new position in Patterson Companies during the fourth quarter valued at $216,000. Hedge funds and other institutional investors own 85.43% of the company’s stock.

Patterson Companies Price Performance

Shares of NASDAQ PDCO opened at $31.34 on Tuesday. The firm has a market cap of $2.77 billion, a P/E ratio of 18.33, a PEG ratio of 2.71 and a beta of 0.73. Patterson Companies, Inc. has a twelve month low of $19.45 and a twelve month high of $31.79. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. The company has a 50 day moving average of $31.12 and a 200 day moving average of $27.42.

Analyst Upgrades and Downgrades

PDCO has been the topic of a number of recent research reports. Morgan Stanley upped their target price on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com started coverage on shares of Patterson Companies in a report on Saturday. They issued a “hold” rating on the stock. Eleven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Patterson Companies presently has an average rating of “Hold” and an average target price of $26.57.

Check Out Our Latest Stock Analysis on Patterson Companies

Patterson Companies Profile

(Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

See Also

Want to see what other hedge funds are holding PDCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Patterson Companies, Inc. (NASDAQ:PDCOFree Report).

Institutional Ownership by Quarter for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.